2,3,4,5-Tetrahydrobenzo[f][1,4]thiazepine 1,1-dioxide, 97%, 250mg

Sodium 3-(Trimethylsilyl)-1-propanesulfonate [1H NMR Standard for D2O Solvent]>98.0%(T)1g

2-Amino-4-hydroxybenzothiazole, 95.0%, 1g

3-(4-tert-Butyl-2,6-dimethylphenyl)-1-propene, 97.0%, 2g

DIETHYL 4,4-DIFLUOROHEPTANEDIOATE, 97.0%, 25g

1-methoxy-3-(methylamino)-2-propanol, 95.0%, 10g

Methyl 5-Bromo-2-chloronicotinate, 97.0%, 1g

4-Oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate, 97%, 25mg

2-Deoxy-D-Galactose, min.99%, pour la biochimie, 1 g, emballage en verre

Incubateur série BF avec mouvement d'air forcé (ventilateur), 114 l, BF 115, 1 pièce

(11bS)-2,6-Bis(4-fluorophenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 97%, 1g

1-Boc-2-Ethynylpyrrolidine, 95.0%, 250mg

5-BROMONAPHTHALEN-2-AMINE, 95%, 250mg